Today: 12 June 2026
Mastercard stock today: MA ends 2025 lower as Wall Street pauses for New Year’s Day
1 January 2026
1 min read

Mastercard stock today: MA ends 2025 lower as Wall Street pauses for New Year’s Day

NEW YORK, January 1, 2026, 11:38 ET — Market closed.

  • Mastercard shares last closed down 1.1% at $570.88 in the year’s final session.
  • U.S. stock markets are shut for New Year’s Day and reopen Friday, Jan. 2.
  • Investors are turning to early-January economic data and Mastercard’s next earnings window for the next catalyst.

Mastercard shares ended the year’s final trading session down 1.1% at $570.88, underperforming a broadly weaker Wall Street tape.

U.S. stock markets are closed on Thursday for the New Year’s Day holiday, leaving investors to reset positions ahead of Friday’s reopen.

The pause matters because payment-network stocks often trade with expectations for consumer spending and travel, which can shift quickly as investors reassess rate cuts, inflation and growth into a new year.

Wall Street’s major indexes ended the final 2025 session lower, with holiday-thinned trading and profit-taking cited as drivers. “It’s perfectly fine in any bull market to have moments of cost,” said Giuseppe Sette, co-founder and president of Reflexivity. Reuters

Mastercard’s decline compared with a 0.8% drop in Visa shares, another card-network bellwether, while American Express also finished lower.

MarketWatch data showed Mastercard’s volume was about 1.7 million shares, below its 50-day average, and the stock sat about 5% under its 52-week high of $601.77.

For investors, the key fundamental watchpoint remains transaction growth. Mastercard earns fees tied to purchase volumes and cross-border activity, a measure of spending that occurs in a different country than the cardholder’s home market and is closely watched as a travel proxy.

Analysts have been publishing previews ahead of Mastercard’s next quarterly report, expecting continued profit growth as card spending holds up and services revenue expands, according to a recent Barchart note.

The earnings date itself is not uniform across market calendars, but several widely used schedules peg Mastercard’s next report for late January, with Nasdaq’s estimate pointing to Jan. 29.

Macro conditions remain the bigger swing factor for the group early in 2026, as investors debate whether rate cuts and earnings growth can extend the rally after three straight years of double-digit gains for the S&P 500.

Before the next session, traders will be watching Friday’s Jan. 2 reopen for any spillover from year-end positioning and thin liquidity.

The next U.S. data catalysts come fast: the Employment Situation report for December 2025 is scheduled for Jan. 9, followed by the Consumer Price Index for December 2025 on Jan. 13, both at 8:30 a.m. ET.

On the company calendar, Mastercard said in a December statement that its quarterly cash dividend will be paid Feb. 9 to shareholders of record as of Jan. 9—dates that can draw near-term focus for income funds alongside any confirmation of the earnings schedule.

Stock Market Today

  • Lendlease Group Shares Seen Undervalued After CEO Change and FY26 Guidance
    June 12, 2026, 5:54 PM EDT. Lendlease Group (ASX:LLC) shares gained 16.67% in a week after announcing Nick O'Neil as new CEO starting September 2026 and reaffirming FY26 earnings per security guidance. Despite a 44.38% year-to-date share price decline, analysts estimate a fair value of A$4.58 versus the closing price of A$2.87, indicating potential undervaluation. Analyst price targets range from A$2.85 to A$6.3, reflecting mixed optimism about the company's project pipeline and execution risks. However, discounted cash flow models suggest a lower fair value of A$2.42, below current prices. Investors face a choice between analyst optimism and cash flow constraints as Lendlease navigates leadership transition and strategic asset sales.

Latest articles

Alumis Shares Surge 16% as Traders Eye New Drug Move

Alumis Shares Surge 16% as Traders Eye New Drug Move

12 June 2026
Alumis soared 15.55% to $24.15 on double average volume after strong analyst support and late-stage psoriasis data, but remains a high-risk, loss-making biotech with no approved products; key investor focus is on Phase 2b lupus data due Q3 and a planned psoriasis NDA filing in Q4, with future stock moves hinging on these clinical and regulatory milestones.
Maase Shares Rise After Times Good Filing

Maase Shares Rise After Times Good Filing

12 June 2026
Maase Inc. (MAAS) jumped 15.73% to $14.86 after a June 12 SEC filing revealed its Times Good acquisition brings AI-computing revenue growth potential but also losses, negative cash flow, and a going-concern warning; investors await proof Maase can turn its AI push into funded projects and improved financials.
Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next
Previous Story

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next

EV Stocks Today: BYD’s weakest growth in five years and Tesla deliveries set up Friday’s trade
Next Story

EV Stocks Today: BYD’s weakest growth in five years and Tesla deliveries set up Friday’s trade

Go toTop